Penicillin G benzathine: Difference between revisions
Jump to navigation
Jump to search
Line 11: | Line 11: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
'''[[ | '''[[Penicillin G benzathine description|Description]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine directions for use|Directions For Use]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Penicillin G benzathine labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== |
Revision as of 17:10, 27 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
BICILLIN L-A®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages
Mechanism of Action
Penicillin G exerts a bactericidal action against penicillin-susceptible microorganisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell-wall peptidoglycan, rendering the cell wall osmotically unstable.[1]
References
- ↑ "BICILLIN L-A (PENICILLIN G BENZATHINE) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS LLC]". Text " accessdate" ignored (help)